Drug Company Execs Agree to Testify on Prescription Prices

Published on January 28, 2024

The chief executive officers at Johnson & Johnson and Merck reportedly dodged a possible subpoena – and have agreed to testify at a Senate hearing in February that will focus on prescription drug prices.

Read Full Article (External Site)